Show simple item record

FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE

dc.contributor.authorSoysal, T.
dc.contributor.authorEskazan, A. E.
dc.contributor.authorOzbek, U.
dc.contributor.authorAr, M. C.
dc.contributor.authorAydin, Y.
dc.contributor.authorAyer, M.
dc.contributor.authorKantarcioglu, B.
dc.contributor.authorArica, D.
dc.contributor.authorDemirel, N.
dc.contributor.authorAydin, D.
dc.contributor.authorTuzuner, N.
dc.contributor.authorBaslar, Z.
dc.contributor.authorSalihoglu, A.
dc.contributor.authorAydin, S. Ongoren
dc.contributor.authorYalniz, F. F.
dc.contributor.authorElverdi, T.
dc.date.accessioned2021-03-04T18:47:25Z
dc.date.available2021-03-04T18:47:25Z
dc.identifier.citationEskazan A. E. , Baslar Z., Ayer M., Kantarcioglu B., Arica D., Demirel N., Aydin D., Yalniz F. F. , Elverdi T., Salihoglu A., et al., "FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE", 19th Congress of the European-Hematology-Association, Milan, İtalya, 12 - 15 Haziran 2014, cilt.99, ss.330-331
dc.identifier.othervv_1032021
dc.identifier.otherav_8c8f423b-8867-4d91-a8d6-ed8b313ac4a1
dc.identifier.urihttp://hdl.handle.net/20.500.12627/95079
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleFIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE
dc.typeBildiri
dc.contributor.departmentIstanbul Haseki Training & Research Hospital , ,
dc.identifier.volume99
dc.contributor.firstauthorID144432


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record